Brought to you by the American Headache Society, the First Contact — Headache In Primary Care podcast breaks down topics in headache medicine for primary care providers and other healthcare professionals seeing patients with headache disorders. The goal of the program is to provide educational resources to empower healthcare professionals and improve headache and migraine care for patients.

First Contact — Headache in Primary Care
Claim This Podcastby American Headache Society
Podcast Overview
Brought to you by the American Headache Society, the First Contact — Headache In Primary Care podcast breaks down topics in headache medicine for primary care providers and other healthcare professionals seeing patients with headache disorders. The goal of the program is to provide educational resources to empower healthcare professionals and improve headache and migraine care for patients.
Language
🇺🇲
Publishing Since
8/31/2020
2 verified contact emails on file for First Contact — Headache in Primary Care
Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.
Recent Episodes

April 16, 2026
Improving Headache Care in Underserved U.S. Communities
<p><strong>Topic:</strong> Improving Headache Care for Underserved Populations</p><p><strong>Hosts:</strong> Mia Minen, MD, MPH, FAHS & Angeliki Vgontzas, MD</p><p><strong>Guest:</strong> Elizabeth Loder, MD, MPH, FAHS</p><p><strong>Description:</strong> Millions of people living with migraine and other headache disorders never make it into a specialist's waiting room, and that gap is far from random. In Season 2, Episode 2 of First Contact: Headache in Primary Care, Drs. Mia Minen and Angeliki Vgontzas speak with Dr. Elizabeth Loder about the systemic barriers that prevent underserved populations from accessing quality headache care. From geographic shortages and insurance hurdles to VIP referral pipelines and language barriers, Dr. Loder breaks down who gets left out and why, and offers practical, affordable strategies primary care providers can use right now. You'll also hear how e-consults, embedded specialty clinics, and professional society guidance are helping bridge the gap for special populations, including pregnant women, adolescents, and elderly patients.</p>

January 13, 2026
Headache Medicine Advocacy: Lessons from Headache on the Hill
<p><strong>Topic:</strong> Headache Medicine Advocacy: Lessons from Headache on the Hill<br><strong>Hosts:</strong> Mia Minen, MD, MPH, FAHS & Angeliki Vgontzas, MD<br><strong>Guests:</strong> Robert Shapiro, MD, PHD, FAHS & Annika Ehrlich, DNP, FNP-C, CNRN, AQH</p><p><strong>Description:</strong> Advocacy is a powerful tool for improving care for people living with migraine and other headache disorders, and clinicians and patients can make an impact together. In Season 2, Episode 1 of First Contact: Headache in Primary Care, Drs. Mia Minen and Angeliki Vgontzas speak with Drs. Robert Shapiro and Annika Ehrlich about how headache advocacy has shaped policy, expanded access to treatments, and helped drive meaningful change through initiatives like Headache on the Hill and the Alliance for Headache Disorders Advocacy (AHDA). You’ll hear practical ways busy clinicians (and patients) can get involved, whether that’s joining advocacy events, writing to representatives, leveraging social media, or simply connecting patients with opportunities to use their voices.</p><p>[00:58] Why advocacy matters in headache medicine and what’s at stake<br>[01:38] Dr. Shapiro’s advocacy journey + the origin of Headache on the Hill<br>[03:57] Dr. Ehrlich on joining headache care and leading AHDA<br>[06:02] The goals of Headache on the Hill and where federal policy falls short<br>[07:40] Advocacy wins: cluster headache oxygen coverage + VA Headache Centers of Excellence<br>[09:15] Why patients’ voices are essential—and how clinicians and patients work together<br>[11:11] How to participate (including virtual options) when time/travel are barriers<br>[12:46] Other ways to get involved: letter writing, webinars, and social media<br>[14:14] How advocacy can counter burnout and restore a sense of momentum<br>[15:10] Advocacy as an antidote to despair and why progress is possible</p><p><a href="https://americanheadachesociety.org/educational-programs/first-contact-program" target="_blank" rel="ugc noopener noreferrer">Learn more</a> about the American Headache Society’s First Contact - Headache in Primary Care program.</p><p><br><a href="https://allianceforheadacheadvocacy.org/" target="_blank" rel="ugc noopener noreferrer">Learn more</a> about getting involved with advocacy.</p>

May 12, 2023
What Primary Care Providers Should Know About Newer Migraine Medications
<p><strong>Topic:</strong> Migraine and New Generation Medications</p> <p><strong>Host:</strong> Mia Minen, MD, MPH, FAAN, FAHS [<a href="https://twitter.com/miaminenmd">@MiaMinenMD</a>]</p> <p><strong>Guest(s):</strong> Claire Sandoe, MD, MSC, FRCPC, Headache Fellow [<a href="https://twitter.com/ClaireSandoe">@ClaireSandoe</a>] | Michael J. Marmura, MD</p> <p><strong>Description:</strong> In recent years, many new medications have been developed and approved for the treatment of headache and migraine disorders. These evidence-based treatments, such as those that target calcitonin gene-related peptide (CGRP), often work better and are better tolerated than older medications which were not designed to treat headache and migraine. In this episode, we review each of these new agents to help primary care providers feel comfortable incorporating them into their treatment plan. How do newer medications differ from earlier medications for migraine and headache disorders? Do they offer patients a better quality of life? Are there any restrictions on who can prescribe these newer migraine medications? Hear the answers to these questions and others from Claire Sandoe, MD, MSC, FRCPC, a headache neurologist at Women’s College Hospital and Assistant Professor at the University of Toronto, and Michael J. Marmura, MD, Associate Professor of Neurology at Thomas Jefferson University with a specialization in headache disorders.</p> <p><strong>[01:42]</strong> How do newer medications differ from earlier medications for migraine and headache disorders?</p> <p><strong>[03:44]</strong> What does the data on new medications tell us about how they can help certain patient populations?</p> <p><strong>[05:40]</strong> Do these newer medications offer patients a better quality of life?</p> <p><strong>[07:31]</strong> How are medications specific to the 5-HT1F receptor, such as lasmiditan, opening up new avenues for treatment?</p> <p><strong>[08:27]</strong> How do you counsel patients who are concerned about the side effects of new medications?</p> <p><strong>[09:56]</strong> What’s next when it comes to the development of new migraine treatments?</p> <p><strong>[11:48]</strong> How does the side effect profile of newer medications compare to that of common older medications?</p> <p><strong>[15:06]</strong> Are there any restrictions on who can prescribe these newer migraine medications? Is there anything else health care providers need to know in terms of prescribing them?</p> <p>Learn more about the American Headache Society’s First Contact - Headache in Primary Care program at <a href="https://americanheadachesociety.org/primarycare/">https://americanheadachesociety.org/primarycare/</a>, check out our Preventive Migraine Treatment page for more on preventive treatment at <a href="https://americanheadachesociety.org/topic/preventive-treatment/">https://americanheadachesociety.org/topic/preventive-treatment/</a> and follow us on Twitter (<a href="https://twitter.com/ahsheadache">@ahsheadache</a>).</p>
23 total episodes available
Deep-dive analytics for First Contact — Headache in Primary Care
Frequently asked questions
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
- What is First Contact — Headache in Primary Care?
- How often does this podcast release new episodes?
This podcast updates daily.
- Where can I listen to this podcast?
This podcast is available on 4 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
- Does this podcast accept guests?
Yes, this podcast regularly features guests.
Legal Disclaimer
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.
